Discovery of Inhibitors for the Ether Lipid-Generating Enzyme AGPS as Anti-Cancer Agents
- 4 September 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 10 (11) , 2589-2597
Abstract
Dysregulated ether lipid metabolism is an important hallmark of cancer cells. Previous studies have reported that lowering ether lipid levels by genetic ablation of the ether lipid-generating enzyme alkyl-glycerone phosphate synthase (AGPS) lowers key structural and oncogenic ether lipid levels and alters fatty acid, glycerophospholipid, and eicosanoid metabolism to impair cancer pathogenicity, indicating that AGPS may be a potential therapeutic target for cancer. In this study, we have performed a small-molecule screen to identify candidate AGPS inhibitors. We have identified several lead AGPS inhibitors and have structurally characterized their interactions with the enzyme and show that these inhibitors bind to distinct portions of the active site. We further show that the lead AGPS inhibitor 1a selectively lowers ether lipid levels in several types of human cancer cells and impairs their cellular survival and migration. We provide here the first report of in situ-active pharmacological tools for inhibiting AGPS, which may provide chemical scaffolds for future AGPS inhibitor development for cancer therapy.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (IG-15208)
- American Cancer Society (RSG14-242-01-TBE)
- Ministero dell'Istruzione, dell'Università e della Ricerca (RBFR10ZJQT, RF-2010-2318330)
- Congressionally Directed Medical Research Programs (W81XWH-15-1-0050)
- Fondazione Telethon (GGP12007)
- National Cancer Institute (R01CA172667)
- Seventh Framework Programme (282510)
This publication has 25 references indexed in Scilit:
- Precursor of ether phospholipids is synthesized by a flavoenzyme through covalent catalysisProceedings of the National Academy of Sciences, 2012
- ZINC: A Free Tool to Discover Chemistry for BiologyJournal of Chemical Information and Modeling, 2012
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer PathogenesisCell, 2010
- ThermoFAD, a Thermofluor®‐adapted flavin ad hoc detection system for protein folding and ligand bindingThe FEBS Journal, 2009
- The Crucial Step in Ether Phospholipid Biosynthesis: Structural Basis of a Noncanonical Reaction Associated with a Peroxisomal DisorderStructure, 2007
- Binding of the Respiratory Chain Inhibitor Antimycin to the Mitochondrial bc1 Complex: A New Crystal Structure Reveals an Altered Intramolecular Hydrogen-bonding PatternJournal of Molecular Biology, 2005
- Ether lipid synthesis: Purification and identification of alkyl dihydroxyacetone phosphate synthase from guinea-pig liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Two distinct quinone‐modulated modes of antimycin‐sensitive cytochrome b reduction in the cytochrome bc1 complexFEBS Letters, 1984
- The mechanism of action of the respiratory inhibitor, antimycinBiochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics, 1973
- Occurrence and nature of O-alkyl and O-alk-1-enyl moieties of glycerol in lipids of morris transplanted hepatomas and normal rat liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1969